Cargando…
Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis
Objective To examine the risk of treatment emergent, cardiovascular serious adverse events associated with varenicline use for tobacco cessation. Design Meta-analysis comparing study effects using four summary estimates. Data sources Medline, Cochrane Library, online clinical trials registries, and...
Autores principales: | Prochaska, Judith J, Hilton, Joan F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344735/ https://www.ncbi.nlm.nih.gov/pubmed/22563098 http://dx.doi.org/10.1136/bmj.e2856 |
Ejemplares similares
-
Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study
por: Svanström, Henrik, et al.
Publicado: (2012) -
Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis
por: Thomas, Kyla H, et al.
Publicado: (2015) -
Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Sterling, Lee H., et al.
Publicado: (2016) -
Tobacco smoking cessation management: integrating varenicline in current practice
por: Galanti, Laurence M
Publicado: (2008) -
Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008)